High-Density Lipoprotein Cholesterol Efflux Capacity as a Surrogate Marker for Major Cardiac Adverse Events in Japanese Patients

MeSH terms

• Biomarkers / analysis
• Cardiovascular Diseases* / blood
• Cardiovascular Diseases* / diagnosis
• Cardiovascular Diseases* / metabolism
• Cardiovascular Diseases* / mortality
• Cholesterol, HDL* / blood
• Cholesterol, HDL* / metabolism
• Heart Disease Risk Factors
• Humans
• Japan / epidemiology
• Macrophages / physiology
• Prognosis
• Protective Factors